肾康栓治疗慢性肾功能衰竭预算影响分析

肾康栓治疗慢性肾功能衰竭预算影响分析

郜文

北京医药卫生经济研究会

收稿日期:2018-10-22 修回日期:2018-10-22 出版日期:2018-09-25

Analysis of Budgetary Effect of Shenkangshuan on Chronic Renal Failure

GAO Wen

Medical and Health Economic Research Association

Received:2018-10-22 Revised:2018-10-22 Online:2018-09-25

摘要/Abstract

摘要： 目的：从医保支付方的角度，评估肾康栓进入国家基本医保目录后，对医保基金可能产生的影响。方法：基于国际药物经济学与结果研究协会公布的预算影响分析指南，采用Excel构建预算影响分析模型。结果：肾康栓纳入医保目录报销后1~5年内，分别节省0.02、0.17、0.35、0.57、0.82亿元。结论：肾康栓纳入医保有利于节省医保资金的支出。

Abstract: Objective：To evaluate the possible impact of shenkangshuan after entering the national basic medical insurance catalogue from the perspective of the medical insurance payment party. Methods：Based on the budget impact analysis guide published by the International Association for Pharmacoeconomics and results research，the budget impact analysis model was built with Excel. Results：After 1 to 5 years of medical insurance reimbursement， shenkangshuan can save 0.02， 0.17， 0.35， 0.57 and 0.82 million yuan respectively. Conclusion：Shenkangshuan is beneficial to save the expenditure of medical insurance funds.

郜文. 肾康栓治疗慢性肾功能衰竭预算影响分析[J]. .

GAO Wen. Analysis of Budgetary Effect of Shenkangshuan on Chronic Renal Failure[J]. .

参考文献

[1] 中医内科常见病诊疗指南西医疾病部分.北京：中国中医药出版社.2008.p196.
[2] 何立群.中医药治疗慢性肾功能衰竭临床和实验研究述评[J].中医药通报,2002,1(2):6-8.
[3] Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet,2012,379(9818):815-822.
[4] Levey AS, Atkins R,Coresh J,et al.Chronic kidney disease as a
global public health problem: approaches and initiatives—a position
statement from Kidney Disease Improving Global Outcomes.Kidney Int,2007,72:247-259
[5] Jha V,Wang A Y M,Wang H Y.The impact of CKD identification in large countries: the burden of illness[J].Nephrology Dialysis Transplantation, 2012, 27(suppl 3): iii32-iii38.
[6] Eknoyan G,Lameire N,Eckardt K U,et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J].Kidney Int,2013,3: 5-14.
[7] 国家统计局[EB/OL].[2016-02-27].
http://data.stats.gov.cn/easyquery.htm?cn=C01
[8] 中华医学会.临床诊疗指南.肾脏病学分册.北京：人民卫生出版社.2011: p209.
[9] 苏国彬,刘旭生,翁俊雄,等.慢性肾脏病门诊口服中成药应用现状调查与分析[J].中国中西医结合杂志,2011,31(8):1074-1079.
[10] 国务院办公厅.关于印发深化医药卫生体制改革2014年工作总结和2015年重点工作任务的通知(国办发[2015] 34号)[EB/OL].(2015-05-09) [2016-6-20]. http://www.gov.cn/zhengce/content/2015-05/09/content_9716.htm
[1] 中医内科常见病诊疗指南西医疾病部分.北京：中国中医药出版社.2008.p196.
[2] 何立群.中医药治疗慢性肾功能衰竭临床和实验研究述评[J].中医药通报,2002,1(2):6-8.
[3] Zhang L,Wang F,Wang L,et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet,2012,379(9818):815-822.
[4] Levey AS, Atkins R,Coresh J,et al.Chronic kidney disease as a
global public health problem: approaches and initiatives—a position
statement from Kidney Disease Improving Global Outcomes.Kidney Int,2007,72:247-259
[5] Jha V,Wang A Y M,Wang H Y.The impact of CKD identification in large countries: the burden of illness[J].Nephrology Dialysis Transplantation, 2012, 27(suppl 3): iii32-iii38.
[6] Eknoyan G,Lameire N,Eckardt K U,et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease[J].Kidney Int,2013,3: 5-14.
[7] 国家统计局[EB/OL].[2016-02-27].
http://data.stats.gov.cn/easyquery.htm?cn=C01
[8] 中华医学会.临床诊疗指南.肾脏病学分册.北京：人民卫生出版社.2011: p209.
[9] 苏国彬,刘旭生,翁俊雄,等.慢性肾脏病门诊口服中成药应用现状调查与分析[J].中国中西医结合杂志,2011,31(8):1074-1079.
[10] 国务院办公厅.关于印发深化医药卫生体制改革2014年工作总结和2015年重点工作任务的通知(国办发[2015] 34号)[EB/OL].(2015-05-09) [2016-6-20]. http://www.gov.cn/zhengce/content/2015-05/09/content_9716.htm

快速检索引用检索图表检索高级检索